This article provides a definitive guide for researchers and drug development professionals on preventing deubiquitination during protein extraction.
This article provides a comprehensive guide for researchers and drug development professionals aiming to optimize assays for characterizing ubiquitin chain binding interactions.
This article provides a comprehensive guide for researchers and drug development professionals seeking to resolve the challenging ubiquitin smears in Western blots.
This article addresses the central challenge in targeted protein degradation: harnessing the specificity of over 600 human E3 ubiquitin ligases for therapeutic applications.
This comprehensive review explores cutting-edge methodologies for enriching low-abundance ubiquitinated proteins, a critical challenge in proteomics and drug discovery.
Accurate detection and quantification of ubiquitination are paramount for advancing our understanding of this crucial post-translational modification in health and disease.
This article provides a comprehensive framework for researchers and drug development professionals to systematically minimize background in ubiquitin immunoprecipitation (IP) experiments.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing the proteasome inhibitor MG-132, a critical tool compound and precursor to clinical agents.
This article addresses the significant challenge of weak immunogenicity in ubiquitin antibodies, a major bottleneck in proteomics and therapeutic development.
This article provides a comprehensive overview of the rapidly evolving field of non-canonical ubiquitination detection.